Home
About
Overview
Sharing Data
ORCID
Help
History (6)
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.
Co-Principal Investigator
High-Throughput Identification of Causal Variants Underlying Cardiac Arrhythmia-Related GWAS Hits
The case of a 29-year-old woman with headaches and diplopia.
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors.
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors. Am J Surg Pathol. 2022 06 01; 46(6):823-831.
View in:
PubMed
subject areas
DNA Copy Number Variations
High-Throughput Nucleotide Sequencing
Humans
Loss of Heterozygosity
Neuroendocrine Tumors
Pancreatic Neoplasms
authors with profiles
Namrata Setia